Editas Medicine
EDITEditas Medicine is a clinical-stage biotechnology company which is developing therapies based on CRISPR–Cas9 gene editing technology. Editas is based in Cambridge, Massachusetts and has facilities in Boulder, Colorado. It was founded in 2013 with funding from Third Rock Ventures, Polaris Partners an …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Editas Medicine
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/3/2025 | Sell | O'neill, Gilmore Neil | CEO | $1.7 | $26,196 |
| 6/3/2025 | Sell | Burkly, Linda | EVP, CHIEF SCIENTIFIC OFFICER | $1.7 | $1,252 |
| 6/3/2025 | Sell | Parison, Amy | SVP, Chief Financial Officer | $1.7 | $769 |
| 3/4/2025 | Sell | Burkly, Linda | EVP, CHIEF SCIENTIFIC OFFICER | $1.7 | $4,946 |
| 3/4/2025 | Sell | O'neill, Gilmore Neil | CEO | $1.7 | $28,452 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)